Literature DB >> 3891596

Monocytes and other infiltrating cells in human colorectal tumours identified by monoclonal antibodies.

C Allen, N Hogg.   

Abstract

Monoclonal antibodies have been used to examine the patterns of infiltrating cells in colorectal tumours staged according to Dukes' classification. MAbs reacting with monocytes, but not tissue Mph, revealed a six-fold increase in monocytes in metastasizing C tumours compared to normal gut. The non-metastasizing B tumours could be divided into one group containing increased numbers of monocytes, and a second group comparable to control gut. T-cell numbers were increased in all tumour stages by an average 1.4-fold, which disguised the lack of consistent pattern in T-cell subset ratios in the tumour stromal tissue. However, in the tumour epithelium, there was a constant decrease in the Ts + c cell subset and a subsequent alteration in T-cell subset ratio in favour of Th + i cells. With the progression from Dukes' Stage B to C, there was an increase in the proportion of monocytes and T cells which were activated as detected by mAbs to the C3b receptor and IL-2 receptor, respectively. These observations suggest that an immune response is in progress in these colorectal tumours and that it is most active in the metastasizing Dukes' C tumours. Whether this response is elicited by the tumour or other elements, whether it is detrimental to tumour growth, or whether it is actively assisting tumour growth and possibly dissemination, are matters of conjecture.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891596      PMCID: PMC1453624     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Macrophage infiltration of breast tumours: a prospective study.

Authors:  I Lauder; W Aherne; J Stewart; R Sainsbury
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

2.  Detection and quantitation of macrophage infiltration into primary human tumors with the use of cell-surface markers.

Authors:  G W Wood; K A Gollahon
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

3.  Immunoglobulin-producing cells in the "transitional" mucosa adjacent to adenocarcinomas of the human large bowel.

Authors:  T O Rognum; P Brandtzaeg; K Baklien; J Hognestad
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

Review 4.  Immunostimulation of the lymphodependent phase of neoplastic growth.

Authors:  R T Prehn
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

5.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

6.  Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity.

Authors:  A Mantovani
Journal:  Int J Cancer       Date:  1978-12       Impact factor: 7.396

7.  T-lymphocytes and macrophages in primary murine fibrosarcomas at different stages in their progression.

Authors:  G W Wood; K A Gollahon
Journal:  Cancer Res       Date:  1978-07       Impact factor: 12.701

8.  Content and distribution of macrophages and lymphocytes in solid malignant human tumours.

Authors:  J L Svennevig; H Svaar
Journal:  Int J Cancer       Date:  1979-12-15       Impact factor: 7.396

9.  Host cells in transplanted murine tumors and their possible relevance to tumor growth.

Authors:  R Evans
Journal:  J Reticuloendothel Soc       Date:  1979-10

10.  The spread of rectal cancer and its effect on prognosis.

Authors:  C E DUKES; H J BUSSEY
Journal:  Br J Cancer       Date:  1958-09       Impact factor: 7.640

View more
  9 in total

1.  [Special aspects of right colon cancer].

Authors:  M Reifferscheid; J Fass; R Hartung; C Mittermayer
Journal:  Langenbecks Arch Chir       Date:  1987

2.  Association of macrophages detected with monoclonal antibody 25 F 9 with progression and pathobiological classification of gastric carcinoma.

Authors:  G Heidl; P Davaris; G Zwadlo; M S Jagoda; S Düchting; E Bierhoff; T Grüter; V Krieg; C Sorg
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 3.  Alleviating oxidative stress in cancer immunotherapy: a role for histamine?

Authors:  K Hellstrand; M Brune; C Dahlgren; M Hansson; S Hermodsson; P Lindnér; U H Mellqvist; P Naredi
Journal:  Med Oncol       Date:  2000-11       Impact factor: 3.064

4.  Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix.

Authors:  W al-Saleh; P Delvenne; J E Arrese; A F Nikkels; G E Piérard; J Boniver
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  CCL2 in the Tumor Microenvironment.

Authors:  Tracy O'Connor; Mathias Heikenwalder
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype.

Authors:  E B Bröcker; G Zwadlo; L Suter; M Brune; C Sorg
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  Lymphocytic infiltration and survival in rectal cancer.

Authors:  J R Jass
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

8.  Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis.

Authors:  L Håkansson; G Adell; B Boeryd; F Sjögren; R Sjödahl
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification.

Authors:  M J Smith; A C Culhane; M Donovan; J C Coffey; B D Barry; M A Kelly; D G Higgins; J H Wang; W O Kirwan; T G Cotter; H P Redmond
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.